Isolated autological double-derived cell population enriched with mesenchymal stem cells (MSCS) and methods for obtaining and using the same

MY214350AActive Publication Date: 2026-07-17ID MEDICAL GROUP AUSTRALIA PTY LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
MY · MY
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-07-14
Publication Date
2026-07-17
Patent Text Reader

Abstract

The present invention relates to an isolated autological double-derived cell population enriched with MSCs and provides detailed methods for obtaining and utilizing these cells for therapeutic purposes. The invention encompasses a unique combination of cells derived from both blood and skin sources, enriched with mesenchymal stem cells (MSCs). The methods described include the isolation of these cells from blood and skin tissues, as well as their subsequent culturing, identification, and administration for therapeutic applications, such as the restoration or enhancement of spermatogenesis and fertility in male subjects. The detailed description encompasses the various steps, procedures, culture conditions, and techniques involved in the acquisition and utilization of the isolated cell population.
Need to check novelty before this filing date? Find Prior Art